Contains updated information on personalized/precision medicine especially as it pertains to the immunotherapies; for example, PDL-1 targeted therapies in many cancers.
Includes new classification of neuroendocrine tumors, new classification and updates of follicular variant of papillary thyroid carcinoma, and a new section on the most common metastatic tumors and utilization of ancillary techniques for diagnosis and molecular studies.